Joseph T. Brozinick
Eli Lilly (United States)(US)Eli Lilly (Singapore)(SG)
Publications by Year
Research Areas
Adipose Tissue and Metabolism, Metabolism, Diabetes, and Cancer, Muscle metabolism and nutrition, Sphingolipid Metabolism and Signaling, Diet and metabolism studies
Most-Cited Works
- → FGF-21 as a novel metabolic regulator(2005)2,064 cited
- → Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin Resistance(2007)1,201 cited
- → A Role for AMP-Activated Protein Kinase in Contraction- and Hypoxia-Regulated Glucose Transport in Skeletal Muscle(2001)923 cited
- → Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin(2010)872 cited
- → An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice(2013)522 cited
- → Muscle glycogen storage after different amounts of carbohydrate ingestion(1988)228 cited